🇺🇸 FDA
Patent

US 10307388

Compositions and methods for diagnosis and treatment of inflammation

granted A61KA61K31/20A61K45/06

Quick answer

US patent 10307388 (Compositions and methods for diagnosis and treatment of inflammation) held by United States of America as represented by the Secretary of the Air Force expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/20, A61K45/06, A61P, A61P1/16